Business
Pharmaceutical company Pfizer asks US regulators to allow emergency use of its experimental COVID-19 vaccine – ABC News
Pharmaceutical company Pfizer formally asks US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited…
Pharmaceutical company Pfizer has formally asked US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month.
Key points:
- How much vaccine is available and when is a moving target, but initial supplies will be scarce
- Globally, Pfizer has estimated it could have 50 million doses available by year’s end
- The US Government has a contract to buy millions of Pfizer-BioNTech doses
The action comes days after Pfizer…
Continue Reading
-
Business17 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General14 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Business22 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035
-
Noosa News17 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success